Features of the gene polymorphism of estrogen and progesterone receptors in women with uterine leiomyoma
- Authors: Osinovskaya N.S.1, Ivaschenko T.E.1, Dzhemlikhanova L.K.2, Baranov V.S.3, Tkachenko A.N.2, Sultanov I.Y.1
-
Affiliations:
- Ott Research Institute of Obstetrics and Gynecology, RAMS
- St. Petersburg State University
- D. O. Ott Institute of Obstetrics and Gynecology
- Issue: Vol 61, No 3 (2012)
- Pages: 109-114
- Section: Articles
- URL: https://bakhtiniada.ru/jowd/article/view/1294
- DOI: https://doi.org/10.17816/JOWD613109-114
- ID: 1294
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Natalya Sergeevna Osinovskaya
Ott Research Institute of Obstetrics and Gynecology, RAMS
Email: natosinovskaya@mail.ru
PhD, senior research fellow of the laboratory of prenatal diagnostics of congenial and hereditary diseases
Tatyana Eduardovna Ivaschenko
Ott Research Institute of Obstetrics and Gynecology, RAMSDr. Sci, Prof., Leading Researcher of the laboratory of prenatal diagnostics of congenial and hereditary diseases
Lyailya Kharryasovna Dzhemlikhanova
St. Petersburg State UniversityPhD, associate professor, Faculty of Medicine, Department of Obstetrics, Gynecology and Reproductology
Vladislav Sergeevich Baranov
D. O. Ott Institute of Obstetrics and Gynecologyhead of lab.for Prenatal Diagnosis, MD, professor
Antonina Nicolaevna Tkachenko
St. Petersburg State Universitystudent (6-th cours), Faculty of Medicine, Department of Obstetrics, Gynecology and Reproductology
Iskender Yuryevich Sultanov
Ott Research Institute of Obstetrics and Gynecology, RAMSassistant of laboratory of prenatal diagnostics of congenial and hereditary diseases
References
- Антропова Е. Ю., Тухватуллина Л. М. Эмболизация маточных артерий в лечении больных миомой матки // Трудный пациент. — 2006. — № 9. — С. 33–35.
- Вихляева Е. М. Молекулярно-генетические детерминанты опухолевого роста и обоснование современной стратегии при лейомиоме матки // Вопросы онкологии. — 2001. — Т. 47, № 2–3. — С. 215–216.
- Иммуногистохимические особенности экспрессии сигнальных молекул в миометрии и эндометрии больных с сочетанными гиперпластическими процессами матки / Смирнова М. Ю. [и др.] // Науч. ведомости Белгородск. гос. ун-та. Сер. Медицина. Фармация. — 2011. — Вып. 13/1, Т. 4, № 99. — С. 11–16.
- Современные представления о молекулярно-генетических основах миомы матки / Егорова О. В. [и др.] // Медицинская генетика. — 2007. — Т. 6, №.9. — С. 11–16.
- Шиляев А. Ю. Лейомиома матки // Гинекология. — 2005. — Т. 7,№ 1. — С. 65–70.
- A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells / Chen W. [et al.] // Clin. Endocrinol. Metab. — 2006. — Vol. 1, № 4. — P. 1296–1304.
- Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen / Migliaccio A. [et al.] // EMBO J. — 1998. — Vol. 17. — P. 2008–2018.
- Analysis of estrogen receptor (ERalpha and ERbeta) and progesterone receptor (PR) polymorphisms in uterine leiomyomas / Massart F. [et al.] // Med. Sci. Monit. — 2003. — Vol. 9, № 1. — Р. 25–30.
- Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk / van Meurs J. B. [et al.] // Hum. Mol. Genet. — 2003. — Vol. 12, № 14. — Р. 1745–1754.
- Association of bone mineral density with polymorphism of the estrogen receptor gene / Kobayashi S. [et al.] // J. Bone Miner. Res. — 1996. — Vol. 11. — P. 306–311.
- BRCA2 mutations in primary breast and ovarian cancers / Lancaster J. M. [et al.] // Nature Genetics. — 1996. — Vol. 13. — P. 238–240.
- Endocrine profile associated with estrogen and progesterone receptors in leiomyoma and normal myometrium / Sadan O. [et al.] // Gynecol. Endocrinol. — 1990. — Vol. 4. — Р. 133–142.
- Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids / Salama S. A. [et al.] // J. Soc. Gynecol. Investig. — 2006. — Vol. 13, № 8. — P. 542–550
- Flake G. P., Andersen J., Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review // Environ. Health. Perspect. — 2003. — Vol. 111. — P. 1037–1054.
- Oestrogen receptor-alfa gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata / Kitawaki J. [et al.] // Hum. Reprod. — 2001. — Vol. 16. — P. 51–55.
- Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene id due to an Alu sequence insertion / Rowe S. M. [et al.] // Cancer Res. — 1995. — Vol. 55. — P. 2743–2745.
- PROGINS Alu sequence insertion is associated with hyperprolactinaemia but not leiomyoma susceptibility / Hsieh Y. Y. [et al.] // Clin. Endocrinol. — 2005. — Vol. 62, № 4. — P. 492–497.
- Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning. A laboratory manual. — New York: Cold Spring Harbor Laboratory Press, 2001. — P. 1–245.
Supplementary files
